» Articles » PMID: 39232740

Splenic Cyst Deroofing Complicated with B Lymphoma

Overview
Publisher Biomed Central
Date 2024 Sep 4
PMID 39232740
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Splenic cysts are uncommon and very rarely malignant therefore their treatment isn't standardized. In case of symptomatic cysts different surgical approaches have been suggested. Primary malignant lymphoma of the spleen comprises less than 1% of non-Hodgkin's lymphomas. To our knowledge, only 203 cases of splenic large B-cell lymphoma (LBCL) have been reported to date and only 2 of them were fibrin-associated splenic cysts.

Case Presentation: 27-year-old model with a 19 × 13 cm splenic cyst without data of malignancy in the preliminary study and therefore treated with laparoscopic deroofing. After histological diagnosis of LBCL with a fibrin/EBV-associated splenic pseudocyst, the patient received 4 cycles of Rituximab and a laparoscopic splenectomy was performed due to resurgence of the pseudocyst. No evidence of malignancy has been found during follow up (EBV viral load every 3 months during the first year, PET-CT every 6 months during the first year and annual afterwards) performed after the splenectomy.

Discussion And Conclusions: The value of tumor markers and radiology for diagnosis of splenic cysts is put into question. Only 60 cases of Fibrin-associated LBCL (FA-LBCL) have been described in the literature therefore there are no treatment guidelines for them even though surgery together with systemic treatment has been the prevalent route with good results in most cases.

References
1.
Golmohammadzadeh H, Maddah G, Shams Hojjati Y, Abdollahi A, Shabahang H . Splenic cysts: Analysis of 16 cases. Caspian J Intern Med. 2016; 7(3):217-221. PMC: 5062182. View

2.
Ballestri S, Lonardo A, Romagnoli D, Losi L, Loria P . Primary lymphoma of the spleen mimicking simple benign cysts: contrast-enhanced ultrasonography and other imaging findings. J Med Ultrason (2001). 2015; 42(2):251-5. DOI: 10.1007/s10396-014-0579-z. View

3.
Boyer D, McKelvie P, de Leval L, Edlefsen K, Ko Y, Aberman Z . Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation. Am J Surg Pathol. 2017; 41(3):299-312. DOI: 10.1097/PAS.0000000000000775. View

4.
Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C . EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1). Cancers (Basel). 2021; 13(18). PMC: 8465149. DOI: 10.3390/cancers13184578. View

5.
Jia L, Xing C, Kandathil A, Rosado F, Chen W, Ramakrishnan Geethakumari P . Fibrin-Associated Large B-Cell Lymphoma (FA-LBCL) Involving Solid Organs as Necrotic Cystic Lesions-A Rare Entity with Potential Diagnostic Pitfalls: A Two-Case Series and Review of the Literature. Int J Surg Pathol. 2023; 32(3):543-550. DOI: 10.1177/10668969231185078. View